Futura Medical (LON:FUM) Shares Climb 6.8% – What’s Next?

Futura Medical plc (LON:FUM) shot up 6.8% on Monday. The company traded as high as GBX 0.20 and last traded at GBX 0.17. Approximately 26,431,033 shares were traded during trading, an increase of 148% from the average daily volume of 10,665,203 shares. The stock had previously closed at GBX 0.16.

Futura Medical Stock Up 21.7%

The stock has a market cap of £2.91 million, a PE ratio of -0.24 and a beta of 0.02. The firm has a 50 day moving average price of GBX 0.26 and a 200 day moving average price of GBX 0.53.

Futura Medical (LON:FUM) last released its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. Equities analysts forecast that Futura Medical plc will post 2.85 earnings per share for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.